Kymera Therapeutics Inc (KYMR)
EBITDA Margin
-277.58%
TTM · Period ending:
KYMR EBITDA Margin
Latest reported-277.58%period ending
Latest reported-277.58%period ending
KYMR TTM EBITDA Margin (-489.17% → -277.58%)
TTM ebitda margin
High-resolution chart · PNG
KYMR ebitda margin history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Margin |
|---|---|
| -277.5805% | |
| -596.0381% | |
| -773.1148% | |
| -655.3597% | |
| -597.2333% | |
| -395.1261% | |
| -459.3729% | |
| -183.8162% | |
| -172.1581% | |
| -189.1806% | |
| -182.2081% | |
| -349.5816% | |
| -298.1149% | |
| -333.604% | |
| -323.8692% | |
| -328.158% | |
| -240.4885% | |
| -189.8591% | |
| -134.0743% | |
| -108.9648% | |
| -87.1953% | |
| -92.8247% | |
| -128.4451% | |
| -184.8887% | |
| -489.1673% |